0 likes | 5 Views
Ibrutinib Intermediates: Advancing Pharmaceutical Excellence<br><br>At Vidgastech, we specialize in the production and supply of high-quality Ibrutinib intermediates, ensuring precision and purity in every step of synthesis. As a key component in the development of Ibrutinib, a groundbreaking Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and other B-cell malignancies, our intermediates meet stringent global standards. Our advanced manufacturing processes, backed by rigorous quality control measures, make us a trusted
E N D